Forbes October 28, 2024
Robert Pearl, M.D.

The American medical system has become undeniably complex, a far cry from the days when doctors made house calls and patients paid directly for care.

With the rise of advanced medical technologies, high-priced procedures and for-profit insurance, U.S. healthcare had—by the late-20th century—transformed into a sprawling and sophisticated industry. As hospitals expanded and insurance options multiplied, individuals and businesses quickly found themselves overwhelmed by the system.

To help manage the growing complexities, a new class of healthcare intermediaries emerged. These “middlemen of medicine” assisted providers, patients and employers with tasks like billing, selecting insurance plans and negotiating drug prices. At a time when healthcare was becoming increasingly convoluted, they offered valuable solutions.

But today, rather than evolving to meet modern...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Pharma, Pharma / Biotech, Provider
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article